Amir Sonnenblick
About
In The Last Decade
Amir Sonnenblick
88 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 98
- Oncology 885
- Molecular Biology 743
- Cancer Research 450
- Immunology 234
- Pulmonary and Respiratory Medicine 212
Countries citing papers authored by Amir Sonnenblick
This map shows the geographic impact of Amir Sonnenblick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Sonnenblick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Sonnenblick more than expected).
Fields of papers citing papers by Amir Sonnenblick
This network shows the impact of papers produced by Amir Sonnenblick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Sonnenblick. The network helps show where Amir Sonnenblick may publish in the future.
Co-authorship network of co-authors of Amir Sonnenblick
This figure shows the co-authorship network connecting the top 25 collaborators of Amir Sonnenblick. A scholar is included among the top collaborators of Amir Sonnenblick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Sonnenblick. Amir Sonnenblick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 17 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 16 | |
| 8 | Comparison of Patient Susceptibility Genes Across Breast Cancer: Implications for Prognosis and Therapeutic Outcomes | 8 |
| 9 | 13 | |
| 10 | 15 | |
| 11 | 26 | |
| 12 | 60 | |
| 13 | 6 | |
| 14 | 106 | |
| 15 | 22 | |
| 16 | 44 | |
| 17 | 14 | |
| 18 | [Update: adjuvant trastuzumab in HER2 positive breast cancer]. | 1 |
| 19 | 25 | |
| 20 | 14 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.